Chronic Illness in Children and Adolescents (Advances in Psychotherapy: Evidence Based Practice)

個数:

Chronic Illness in Children and Adolescents (Advances in Psychotherapy: Evidence Based Practice)

  • 在庫がございません。海外の書籍取次会社を通じて出版社等からお取り寄せいたします。
    通常6~9週間ほどで発送の見込みですが、商品によってはさらに時間がかかることもございます。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合がございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 96 p.
  • 言語 ENG
  • 商品コード 9780889373198
  • DDC分類 618.9204

Full Description

Management of chronic illness in children and adolescents often is a multifaceted challenge that requires the attention and expertise of individuals from a variety of disciplines that include psychology, psychiatry, social work, and medicine. The aim of this book is to provide readers with a practical overview of the definitions, characteristics, theories and models, diagnostic and treatment indications, and relevant aspects and methods of evidence-based psychosocial treatments for chronic illness in children and adolescents. Although treatments and research for chronic conditions are reviewed in general, particular attention is directed at asthma, cancer, cystic fibrosis, diabetes mellitus, and sickle cell disease due to the high incidence of these chronic diseases among children and adolescents. Case vignettes and suggestions for further reading are provided for the interested reader."The Advances in Psychotherapy" series has been developed and is edited with the support of the Society of Clinical Psychology (APA Division 12).
In conjunction with the Society, a system of home study continuing education courses has been developed for each book that an individual can complete on the web.

Contents

Acknowledgments; 1 Description; 1.1 Terminology; 1.2 Definition; 1.3 Epidemiology: Incidence and Prevalence; 1.4 Course and Prognosis: Asthma * Cancer * Cystic Fibrosis * Diabetes Mellitus * Sickle Cell Disease; 1.5 Differential Diagnosis; 1.6 Comorbidities: Asthma * Cancer * Cystic Fibrosis * Diabetes Mellitus * Sickle Cell Disease; 1.7 Diagnostic Procedures and Documentation; 2 Theories and Models of the Disorder; 2.1 Risk Factors: Disease and Disability Parameters * Genetic Disorders * Intrauterine Growth Retardation, Prematurity, and Low Birth Weight * Teratogens * Disease Severity * Functional Independence * Psychosocial Stressors; 2.2 Resistance Factors: Intrapersonal Factors; 2.3 Social-Ecological Factors: Family Functioning * Financial Resources * Stress Processing; 2.4 Applying the Models to Sickle Cell Disease; 3 Diagnosis and Treatment Indications; 3.1 Caregiver and Child Interviews; 3.2 Behavior; 3.3 Cognition; 3.4 Affect; 3.5 Adherence; 3.6 Stress and Coping; 3.7 Quality of Life; 3.8 Family Variables; 3.9 Summary; 4 Treatment; 4.1 Methods of Treatment: Behavior Therapy * Cognitive-Behavior Therapy * Behavioral and Cognitive-Behavioral Interventions - Empirical Support and Clinical Trials * Psychological Adjustment * Psychosocial Factors, Coping, and Pain Management * Adherence * Family Systems Interventions * Parent Training * Group Therapy * Peer Group Interventions * Peer Support Groups * Electronic Peer Support Groups * Self-Regulatory Skill Training, Self-Management, and Psychoeducational Strategies; 4.2 Mechanisms of Action; 4.3 Efficacy and Prognosis; 4.4 Variations and Combinations of Methods; 4.5 Problems in Carrying out the Treatment: Individual Barriers * Family Barriers * Provider Barriers * System and Setting-Based Barriers; 4.6 Multicultural Issues; 4.7 Summary; 5 Case Vignette; 6 Further Reading; 7 References; 8 Appendix: Tools and Resources.

最近チェックした商品